When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GMAB - Novartis' ofatumumab successful in late-stage MS studies
Genmab A/S
Novartis (NYSE:NVS) announces positive data from two Phase 3 clinical trials, ASCLEPIOS I and ASCLEPIOS II, evaluating monthly injections of ofatumumab versus daily oral doses of teriflunomide [Sanofi's (NASDAQ:SNY) Aubagio] in adult patients with relapsing forms of multiple sclerosis (RMS).
More news on: Novartis AG, Sanofi, Genmab A/S, Healthcare stocks news,